138 related articles for article (PubMed ID: 2025432)
1. Clinical applications of magnetic resonance contrast media in the head.
Runge VM
Top Magn Reson Imaging; 1991 Mar; 3(2):19-40. PubMed ID: 2025432
[TBL] [Abstract][Full Text] [Related]
2. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
Mihara F; Gupta KL; Righi AM
Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
[TBL] [Abstract][Full Text] [Related]
3. [3 Tesla magnetic resonance tomography--clinical applications].
Trattnig S
Wien Med Wochenschr Suppl; 2002; (113):22-7. PubMed ID: 12621832
[TBL] [Abstract][Full Text] [Related]
4. T1-weighted fluid-attenuated inversion recovery and T1-weighted fast spin-echo contrast-enhanced imaging: a comparison in 20 patients with brain lesions.
Al-Saeed O; Ismail M; Athyal RP; Rudwan M; Khafajee S
J Med Imaging Radiat Oncol; 2009 Aug; 53(4):366-72. PubMed ID: 19695043
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
Zhou ZR; Shen TZ; Chen XR; Peng WJ
Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
7. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
[TBL] [Abstract][Full Text] [Related]
8. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
[TBL] [Abstract][Full Text] [Related]
9. Value of magnetization transfer contrast in intracranial enhancing and nonenhancing lesions with paramagnetic contrast agents.
Hamatake S; Korogi Y; Sakamoto Y; Ikushima I; Hirai T; Takahashi M
Radiat Med; 1997; 15(5):295-303. PubMed ID: 9445151
[TBL] [Abstract][Full Text] [Related]
10. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
Wu X; Wang H; Chen F; Jin L; Li J; Feng Y; DeKeyzer F; Yu J; Marchal G; Ni Y
Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
[TBL] [Abstract][Full Text] [Related]
11. Assessment of kainate toxicity using contrast enhanced magnetic resonance imaging.
Beravs K; Frangez R; Demsar F
Pflugers Arch; 2000; 440(5 Suppl):R153-4. PubMed ID: 11005651
[TBL] [Abstract][Full Text] [Related]
12. Basic principles of magnetic resonance contrast agents.
Kirsch JE
Top Magn Reson Imaging; 1991 Mar; 3(2):1-18. PubMed ID: 2025431
[TBL] [Abstract][Full Text] [Related]
13. The use of MR contrast in nonneoplastic disease of the brain.
Runge VM
Top Magn Reson Imaging; 1995; 7(3):158-67. PubMed ID: 7654394
[TBL] [Abstract][Full Text] [Related]
14. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
Welsch GH; Mamisch TC; Hughes T; Zilkens C; Quirbach S; Scheffler K; Kraff O; Schweitzer ME; Szomolanyi P; Trattnig S
Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
[TBL] [Abstract][Full Text] [Related]
15. [Meningeal enhancement of magnetic resonance imaging in a patient with liqour fistula].
Jokelainen M; Suoranta H
Duodecim; 1997; 113(8):731-4. PubMed ID: 11466872
[No Abstract] [Full Text] [Related]
16. 3.0-T functional brain imaging: a 5-year experience.
Scarabino T; Giannatempo GM; Popolizio T; Tosetti M; d'Alesio V; Esposito F; Di Salle F; Di Costanzo A; Bertolino A; Maggialetti A; Salvolini U
Radiol Med; 2007 Feb; 112(1):97-112. PubMed ID: 17310287
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence of non-neoplastic, magnetic resonance imaging-enhancing tissue by 5-aminolevulinic acid: case report.
Miyatake S; Kuroiwa T; Kajimoto Y; Miyashita M; Tanaka H; Tsuji M
Neurosurgery; 2007 Nov; 61(5):E1101-3; discussion E1103-4. PubMed ID: 18091261
[TBL] [Abstract][Full Text] [Related]
18. Contrast agents: magnetic resonance.
Burtea C; Laurent S; Vander Elst L; Muller RN
Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance angiography in intracranial vascular disease.
Pernicone JR; Thorp KE; Ouimette MV; Siebert JE; Potchen EJ
Semin Ultrasound CT MR; 1992 Aug; 13(4):256-73. PubMed ID: 1503794
[TBL] [Abstract][Full Text] [Related]
20. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits.
Zheng J; Ochoa E; Misselwitz B; Yang D; El Naqa I; Woodard PK; Abendschein D
Invest Radiol; 2008 Jan; 43(1):49-55. PubMed ID: 18097277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
